Carbon Nanotube-Mediated Photothermal Disruption of Endosomes/Lysosomes Reverses Doxorubicin Resistance in MCF-7/ADR Cells

被引:34
|
作者
Pai, Chin-Ling [1 ]
Chen, Yu-Chun [2 ]
Hsu, Chia-Yen [2 ]
Su, Hong-Lin [1 ,3 ]
Lai, Ping-Shan [1 ,2 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 402, Taiwan
[2] Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan
[3] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan
关键词
Carbon Nanotubes; Doxorubicin; Drug Resistance; Breast Cancer; Photothermal Treatments; BREAST-CANCER CELLS; DRUG-DELIVERY; IN-VIVO; PHOTOCHEMICAL INTERNALIZATION; MULTIDRUG-RESISTANCE; P-GLYCOPROTEINS; TRANSPORTERS; THERAPY; FUNCTIONALIZATION; ANTIBODY;
D O I
10.1166/jbn.2016.2133
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Cancer is the leading cause of human death worldwide. Although many scientists work to fight this disease, multiple drug resistance is a predominant obstacle for effective cancer therapy. In drug-resistant MCF-7/ADR cells, the acidic organelles with lower pH value than normal one can cause the protonation of anthracycline drugs, inducing drug accumulation in these organelles. In this study, single-walled carbon nanotubes with polyethylene glycol phospholipids surface modification (PEGylated SWNTs) were utilized as near infrared-activated drug carriers for doxorubicin (DOX) delivery against MCF-7/ADR cells. Our results showed that a concentration-dependent temperature increase was observed in a solution of PEGylated SWNTs with 808 nm laser irradiation, whereas a water solution showed no significant changes in temperature under a thermal camera using the same irradiation dose. Interestingly, PEGylated DOX-SWNTs enhanced the nuclear accumulation of DOX with 808 nm irradiation whereas free DOX or PEGylated DOX-SWNTs revealed discrete red spots in MCF-7/ADR cells by confocal microscopic observation. Cell viability of PEGylated DOX-SWNTs-treated cells was also significantly decreased after 808 nm laser irradiation. Thus, photothermally activated PEGylated SWNTs can be a potential nanocarrier to deliver DOX into cancer cells and successfully overcome drug-resistant behavior in MCF-7/ADR breast cancer cells.
引用
收藏
页码:619 / 629
页数:11
相关论文
共 50 条
  • [11] Novel Submicron Emulsion System Loaded with Doxorubicin Overcome Multi-Drug Resistance in MCF-7/ADR Cells
    Zhou, W. P.
    Hua, H. Y.
    Sun, P. C.
    Zhao, Y. X.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 (04) : 499 - 504
  • [12] Pien Tze Huang Overcomes Doxorubicin Resistance and Inhibits Epithelial-Mesenchymal Transition in MCF-7/ADR Cells
    Chen, Xi
    Qi, Fei
    Shen, A-ling
    Chu, Jian-feng
    Sferra, Thomas Joseph
    Chen, You-qin
    Peng, Jun
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (08) : 598 - 603
  • [13] Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
    Jinrong Wei
    Yong Zhou
    Guo-Qin Jiang
    Dong Xiao
    Cancer Cell International, 14
  • [14] Silencing of ETS1 reverses adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1
    Wei, Jinrong
    Zhou, Yong
    Jiang, Guo-Qin
    Xiao, Dong
    CANCER CELL INTERNATIONAL, 2014, 14
  • [15] Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins
    Kasaian, Jamal
    Mosaffa, Fatemeh
    Behravan, Javad
    Masullo, Milena
    Piacente, Sonia
    Ghandadi, Morteza
    Iranshahi, Mehrdad
    FITOTERAPIA, 2015, 103 : 149 - 154
  • [16] ROLE OF FOXO1 IN THE ACQUISITION OF DOXORUBIN RESISTANCE IN MCF-7/ADR CELLS
    Kang, Keon Wook
    Choi, Hoo-Kyun
    DRUG METABOLISM REVIEWS, 2008, 40 : 104 - 104
  • [17] Triptolide reverses MCF-7/ADR cell resistance by down-regulating P-glycoprotein expression
    Zhang, Pu-Rong
    Zhang, Jian-Hui
    Yu, Miao
    Zhang, Xin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1513 - 1521
  • [18] Saikosaponin A, an active glycoside from Radix bupleuri, reverses P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cells and HepG2/ADM cells
    Ye, Rui-Ping
    Chen, Zhen-Dong
    XENOBIOTICA, 2017, 47 (02) : 176 - 184
  • [19] Teratogenic jervine increases the activity of doxorubicin in MCF-7/ADR cells by inhibiting ABCB1
    Liu, Ming
    Lu, Xuxiu
    Zhang, Jinman
    Zhao, Xingzeng
    Zhang, Wei
    Lin, Xiukun
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 117
  • [20] StemRegenin-1 Reverses Drug Resistance of MCF-7/ADR Cells via AhR/ABC Transports and AhR/UGTs Pathways
    Zhang, Yang
    Ma, Yu-Chen
    Song, Jue
    Jin, Yong
    Bao, Yan-Ni
    CURRENT PROTEOMICS, 2024, 21 (02) : 113 - 128